Published On: Wed, Oct 19th, 2016

Latest Analyst Reports On Medtronic, Inc.


Recently stock market analysts have updated their consensus ratings on shares of Medtronic, Inc. (NYSE:MDT).

Most recent broker ratings

09/20/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at UBS. They now have a USD 96 price target on the stock.

08/26/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 95 price target on the stock.

08/26/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 100 price target on the stock.

08/26/2016 – Medtronic, Inc. had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 94 price target on the stock.

08/23/2016 – Citigroup began new coverage on Medtronic, Inc. giving the company a “buy” rating. They now have a USD 102 price target on the stock.

07/06/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Goldman Sachs.

06/27/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 86.5 price target on the stock.

06/27/2016 – Medtronic, Inc. had its “neutral” rating reiterated by analysts at BTIG Research.

06/20/2016 – Medtronic, Inc. had its “hold” rating reiterated by analysts at Argus.

06/15/2016 – Medtronic, Inc. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 94 price target on the stock.

06/08/2016 – Guggenheim began new coverage on Medtronic, Inc. giving the company a “neutral” rating.

06/02/2016 – Medtronic, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 92 price target on the stock.

06/01/2016 – Medtronic, Inc. had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 85 price target on the stock.

06/01/2016 – Medtronic, Inc. had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 82 price target on the stock.

05/12/2016 – Medtronic, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 87 price target on the stock.

Medtronic, Inc. has a 50 day moving average of 85.79 and a 200 day moving average of 84.12. The stock’s market capitalization is 115.46B, it has a 52-week low of 71.03 and a 52-week high of 89.27.

The share price of the company (NYSE:MDT) was up +1.19%, with a high of 83.86 during the day and the volume of Medtronic, Inc. shares traded was 3510342.